blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1675833

EP1675833 - 1H-IMIDAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.12.2011
Database last updated on 15.11.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Abbott Healthcare Products B.V.
C.J. van Houtenlaan 36
1381 CP Weesp / NL
[2010/21]
Former [2006/27]For all designated states
Solvay Pharmaceuticals B.V.
C.J. van Houtenlaan 36
1381 CP Weesp / NL
Inventor(s)01 / LANGE, Josephus H.M.
IPSI Department C.J. van Houtenlaan 36
NL-1381 CP Weesp / NL
02 / KRUSE, Cornelis G.
IPSI Department C.J. van Houtenlaan 36
NL-1381 CP Weesp / NL
03 / VAN STUIVENBERG, Herman H.
IPSI Department C.J. van Houtenlaan 36
NL-1381 CP Weesp / NL
04 / KEIZER, Hiskias G.
IPSI Department C.J. van Houtenlaan 36
NL-1381 CP Weesp / NL
 [2006/27]
Representative(s)Aerts, Robert Jaap, et al
Octrooibureau Zoan B.V. IPSI Department P.O. Box 140
1380 AC Weesp / NL
[2009/48]
Former [2006/27]Aerts, Robert Jaap, et al
Octrooibureau Zoan B.V. P.O. Box 140
NL-1380 AC Weesp / NL
Application number, filing date04791252.219.10.2004
[2006/27]
WO2004EP52575
Priority number, dateEP2003010386720.10.2003         Original published format: EP 03103867
US20030512105P20.10.2003         Original published format: US 512105 P
[2006/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005040130
Date:06.05.2005
Language:EN
[2005/18]
Type: A1 Application with search report 
No.:EP1675833
Date:05.07.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 06.05.2005 takes the place of the publication of the European patent application.
[2006/27]
Type: B1 Patent specification 
No.:EP1675833
Date:26.01.2011
Language:EN
[2011/04]
Search report(s)International search report - published on:EP06.05.2005
ClassificationIPC:C07D233/90, A61K31/417, A61P3/04
[2006/27]
CPC:
C07D233/90 (EP,KR); A61K31/4164 (KR); A61K45/06 (KR);
A61P1/00 (EP); A61P1/04 (EP); A61P1/08 (EP);
A61P1/12 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P15/10 (EP); A61P21/02 (EP);
A61P25/00 (EP); A61P25/04 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P25/36 (EP); A61P27/06 (EP);
A61P29/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D401/12 (KR); C07D403/06 (KR); A61K2300/00 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/27]
Extension statesALNot yet paid
HR08.02.2006
LT08.02.2006
LV08.02.2006
MKNot yet paid
TitleGerman:1H-IMIDAZOLDERIVATE ALS MODULATOREN DES CANNABINOIDREZEPTORS[2006/27]
English:1H-IMIDAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS[2006/27]
French:DERIVES DE 1H-IMIDAZOLE COMME MODULATEURS DU RECEPTEUR DE CANNABINOIDES[2006/27]
Entry into regional phase08.02.2006National basic fee paid 
08.02.2006Designation fee(s) paid 
08.02.2006Examination fee paid 
Examination procedure21.03.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.02.2006Examination requested  [2006/33]
11.07.2007Despatch of a communication from the examining division (Time limit: M04)
24.08.2007Reply to a communication from the examining division
13.11.2009Communication of intention to grant the patent
08.03.2010Fee for grant paid
08.03.2010Fee for publishing/printing paid
Opposition(s)27.10.2011No opposition filed within time limit [2012/01]
Fees paidRenewal fee
08.02.2006Renewal fee patent year 03
11.12.2007Renewal fee patent year 04
31.10.2008Renewal fee patent year 05
02.11.2009Renewal fee patent year 06
02.11.2010Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.10.200704   M06   Fee paid on   11.12.2007
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
HU26.01.2011
IT26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
TR26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
GB19.10.2011
IE19.10.2011
LU19.10.2011
[2013/45]
Former [2013/44]AT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IT26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
TR26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
GB19.10.2011
IE19.10.2011
LU19.10.2011
Former [2013/25]AT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IT26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
GB19.10.2011
IE19.10.2011
LU19.10.2011
Former [2012/47]AT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IT26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
GB19.10.2011
IE19.10.2011
Former [2012/36]AT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IT26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
GB19.10.2011
Former [2012/23]AT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IT26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
Former [2011/50]AT26.01.2011
BE26.01.2011
CY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
NL26.01.2011
PL26.01.2011
RO26.01.2011
SE26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
Former [2011/47]AT26.01.2011
BE26.01.2011
CY26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
NL26.01.2011
PL26.01.2011
SE26.01.2011
SI26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
Former [2011/39]AT26.01.2011
BE26.01.2011
CY26.01.2011
FI26.01.2011
NL26.01.2011
PL26.01.2011
SE26.01.2011
SI26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
Former [2011/37]BE26.01.2011
CY26.01.2011
FI26.01.2011
PL26.01.2011
SE26.01.2011
SI26.01.2011
BG26.04.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
Former [2011/36]PL26.01.2011
SE26.01.2011
GR27.04.2011
ES07.05.2011
PT26.05.2011
Cited inInternational search[DA]WO03027076  (SOLVAY PHARM BV [NL], et al) [DA] 1,8* the whole document *;
 [DA]WO03063781  (MERCK & CO INC [US], et al) [DA] 1,8 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.